Novo Nordisk announced today that the US Food and Drug Administration (FDA) has approved Rybelsus®, the only oral GLP-1 ...

There’s a need in secondary prevention for personalized risk estimates to motivate patients and guide care, researchers say.

Please provide your email address to receive an email when new articles are posted on . The CV benefits of BP lowering, for both primary and secondary prevention, were found to be proportional to the ...

Routine screening for inflammation by measuring high-sensitivity C-reactive protein can help identify individuals at elevated ...

A risk calculator that incorporates established cardiovascular risk factors and additional cardiac biomarkers, such as high-sensitivity C-reactive protein (hs-CRP) and N-terminal pro-B-type ...

Amgen Inc. (NASDAQ:AMGN) is one of the best growth stocks to buy now. On October 2, Amgen announced that its landmark Phase 3 VESALIUS-CV clinical trial met its dual primary endpoints, confirming that ...

"Aspirin should be reserved for secondary prevention in type 2 diabetes" was the title of a debate at the International Diabetes Federation's 2021 virtual meeting. The use of daily low-dose aspirin ...

A new meta-analysis of trials evaluating aspirin for primary prevention of cardiovascular disease has found no overall benefit, with aspirin use associated with a lower risk of cardiovascular events ...

INGELHEIM, Germany--(BUSINESS WIRE)--EFFISAYIL ™ 2 met its primary and key secondary endpoint, demonstrating that spesolimab, an anti-interleukin-36 receptor antibody, can prevent flares in ...

New guidelines recommend aspirin use in primary prevention for people ages 40 to 70 years old who are at higher risk of a first cardiovascular event, but not for those over 70. Yet, people over 70 are ...